Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1997 5
1998 1
1999 3
2000 3
2001 1
2002 3
2003 3
2004 4
2005 6
2006 6
2007 4
2008 3
2009 5
2010 7
2011 3
2012 6
2013 9
2014 7
2015 6
2016 8
2017 11
2018 5
2019 9
2020 8
2021 13
2022 11
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

128 results
Results by year
Filters applied: . Clear all
Page 1
Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of EBMT and ISCT (JACIE).
Sharrack B, Saccardi R, Alexander T, Badoglio M, Burman J, Farge D, Greco R, Jessop H, Kazmi M, Kirgizov K, Labopin M, Mancardi G, Martin R, Moore J, Muraro PA, Rovira M, Sormani MP, Snowden JA; European Society for Blood and Marrow Transplantation (EBMT) Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of the International Society for Cellular Therapy (ISCT) and EBMT (JACIE). Sharrack B, et al. Among authors: muraro pa. Bone Marrow Transplant. 2020 Feb;55(2):283-306. doi: 10.1038/s41409-019-0684-0. Epub 2019 Sep 26. Bone Marrow Transplant. 2020. PMID: 31558790 Free PMC article.
Immune Reconstitution Following Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis: A Review on Behalf of the EBMT Autoimmune Diseases Working Party.
Cencioni MT, Genchi A, Brittain G, de Silva TI, Sharrack B, Snowden JA, Alexander T, Greco R, Muraro PA. Cencioni MT, et al. Among authors: muraro pa. Front Immunol. 2022 Feb 1;12:813957. doi: 10.3389/fimmu.2021.813957. eCollection 2021. Front Immunol. 2022. PMID: 35178046 Free PMC article. Review.
Antibody-mediated cell depletion therapies in multiple sclerosis.
Mariottini A, Muraro PA, Lünemann JD. Mariottini A, et al. Among authors: muraro pa. Front Immunol. 2022 Sep 12;13:953649. doi: 10.3389/fimmu.2022.953649. eCollection 2022. Front Immunol. 2022. PMID: 36172350 Free PMC article. Review.
Emerging therapies for multiple sclerosis.
Muraro PA, Bielekova B. Muraro PA, et al. Neurotherapeutics. 2007 Oct;4(4):676-92. doi: 10.1016/j.nurt.2007.07.003. Neurotherapeutics. 2007. PMID: 17920549 Free PMC article. Review.
Safety, tolerability, and activity of mesenchymal stem cells versus placebo in multiple sclerosis (MESEMS): a phase 2, randomised, double-blind crossover trial.
Uccelli A, Laroni A, Ali R, Battaglia MA, Blinkenberg M, Brundin L, Clanet M, Fernandez O, Marriot J, Muraro P, Nabavi SM, Oliveri RS, Radue E, Ramo Tello C, Schiavetti I, Sellner J, Sorensen PS, Sormani MP, Wuerfel JT, Freedman MS; MESEMS investigators. Uccelli A, et al. Among authors: muraro p. Lancet Neurol. 2021 Nov;20(11):917-929. doi: 10.1016/S1474-4422(21)00301-X. Lancet Neurol. 2021. PMID: 34687636
128 results